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ABSTRACT
Environmental disruption of molecular clocks promoted liver carcinogenesis 
and accelerated cancer progression in rodents. We investigated the specific role 
of clock gene Period 2 (Per2) for liver carcinogenesis and clock-controlled cellular 
proliferation, genomic instability and inflammation. We assessed liver histopathology, 
and determined molecular and physiology circadian patterns in mice on chronic 
diethylnitrosamine (DEN) exposure according to constitutive Per2 mutation. First, 
we found that Per2m/m liver displayed profound alterations in proliferation gene 
expression, including c-Myc derepression, phase-advanced Wee1, and arrhythmic 
Ccnb1 and K-ras mRNA expressions, as well as deregulated inflammation, through 
arrhythmic liver IL-6 protein concentration, in the absence of any DEN exposure. 
These changes could then make Per2m/m mice more prone to subsequently develop 
liver cancers on DEN. Indeed, primary liver cancers were nearly fourfold as frequent 
in Per2m/m mice as compared to wild-type (WT), 4 months after DEN exposure. The 
liver molecular clock was severely disrupted throughout the whole carcinogenesis 
process, including the initiation stage, i.e. within the initial 17 days on DEN. Per2m/m 
further exhibited increased c-Myc and Ccnb1 mean 24h expressions, lack of P53 
response, and arrhythmic ATM, Wee1 and Ccnb1 expressions. DEN-induced tumor 
related inflammation was further promoted through increased protein concentrations 
of liver IL-6 and TNF-α as compared to WT during carcinogenesis initiation. Per2 
mutation severely deregulated liver gene or protein expressions related to three 
cancer hallmarks, including uncontrolled proliferation, genomic instability, and tumor 
promoting inflammation, and accelerated liver carcinogenesis several-fold. Clock gene 
Per2 acted here as a liver tumor suppressor from initiation to progression.
INTRODUCTION
Hepatocellular carcinoma (HCC) is the sixth 
most frequent cancer and the third most common 
cause of cancer mortality worldwide [1]. Clock gene 
Per2 plays a central role in the prominent circadian 
regulation of liver metabolism and proliferation [2, 3]. 
Here we aimed at determining the role of Per2 in liver 
carcinogenesis. To address this question, chronic exposure 
to diethylnitrosamine (DEN) was used as a model for 
inducing rodent HCC, whose histology and genetic 
signature have been considered to be similar to poor 
prognosis human HCC [4].
Circadian rhythms with an about 24-h period 
characterize the expression patterns of 10-40% of mouse 
liver transcripts [5, 6]. These molecular rhythms are 
controlled by a genetic molecular clock in each cell [7]. 
The molecular oscillator involves an activation loop, 
where Clock or NPas2 and Bmal1 activate the transcription 
of Period (Per) genes 1, 2 and 3, Cryptochrome (Cry) 
genes 1/2, Rev-erbα/β and Dec 1/2. In turn, the Per, Cry, 
Rev-erb and Dec genes inhibit their own transcription and 
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that of other clock genes through the interaction of their 
protein heterodimers with the CLOCK::BMAL1 protein 
heterodimer or clock gene promoters [8]. Circadian clocks 
regulate nutrient and xenobiotic metabolism, immune 
response, cell division cycle, and cell death and survival 
[5, 6, 9, 10]. Messenger RNA (mRNA) and protein 
expression rhythms have been identified in mammalian 
tissues, in cell populations and in single cells [8, 11]. 
The molecular rhythms are redundantly controlled by 
both genetic circadian clocks and physiological rhythms, 
which build up the Circadian Timing System (CTS) [7, 
12]. Mammalian CTS coordination and adjustment to 
environmental cycles is insured by the suprachiasmatic 
nuclei (SCN), a neuronal pacemaker located in the anterior 
hypothalamus [8].
Clock gene Per2 is robustly and rhythmically 
expressed in liver and almost all mammalian tissues 
[13]. In vitro studies showed that Per2 overexpression 
in malignant cells was associated with decreased cell 
proliferation and increased apoptosis resulting from P53 
up-regulation and the down-regulation of Cyclin B1 
(CCNB1), B-cell lymphoma 2 (Bcl2) and c-Myc [14–16].
Mice with constitutive Per2 mutation (Per2m/m) 
were produced with a deletion in the PAS domain of Per2 
gene, and have been maintained by breeding [17]. The 
Per2m/m mice, displayed an alteration of the regulatory 
molecular circadian clock circuitry, resulting from a 
rapidly degraded non-functional PER2 protein, as well 
as decreased apoptosis and accelerated cell cycling [18]. 
This might account for Per2m/m mice developing more 
spontaneous and gamma-radiation-induced cancers [18, 
19], and displaying enhanced susceptibility to anticancer 
chemotherapy [20]. Moreover, oncogene c-Myc was 
upregulated, while P53 was down regulated in the liver 
of both Per2m/m [18] and mice on chronic jet lag, with 
ablated Per2 circadian transcription in liver [21] This 
could explain the significant increase of DEN-induced 
liver cancers in mice or rats exposed to constant light 
or iterative shifts in light-dark cycles [22, 23]. DEN 
carcinogenesis first involves the occurrence of dysplastic 
foci with altered hepatocytes. Such reversible “initiation” 
stage of experimental liver carcinogenesis occurs during 
the initial 2-4 weeks of exposure [24–26]. The hyperplastic 
foci then develop into neoplastic hepatocellular carcinoma 
nodules, following exposure to a promoter agent, or 
continued DEN administration for an additional 4-8 weeks 
[25, 26]. Liver cancer nodules subsequently progress.
Here we show that Per2 mutation fostered three 
critical liver cancer hallmarks, during the initiation 
stage. DEN further profoundly disrupted the circadian 
timing system during the promotion stage. This effect 
was most prominent in Per2m/m mice, with a further 
deterioration during the progression stage. Overall, Per2 
loss-of-function resulted in a fourfold increase in DEN-
induced hepatocarcinoma nodules as compared to clock-
proficient mice.
RESULTS
Per2 control of selected liver carcinogenesis 
pathways
The regulatory role of clock gene Per2 was first 
investigated for circadian clock, proliferation, genomic 
instability, and inflammation, through comparing selected 
gene or protein circadian expressions in the liver of Wild-
Type (WT) and Per2m/m mice. Samples were obtained 
in non-DEN exposed animals at 6 different time points, 
located 4 h apart.
The mRNA expression of core clock gene Bmal1 
displayed marked and statistically significant 24 h changes 
both in WT and Per2m/m mice (Figure 1A). This was also 
the case for all other clock genes including Rev-erbα, 
Clock, Cry1, and Cry2 (Supplementary Figure S1A). 
Circadian rhythms with τ= 24 h were validated with 
Cosinor for each clock gene expression in each genotype, 
except for Clock in Per2m/m. Yet, circadian transcription of 
Bmal1, Rev-erbα, Cry1, and Cry2 were phase-advanced 
by 2- to 5-h, and circadian amplitudes of Bmal1, Rev-
erbα, and Cry1 were dampened by 19% to 59% in Per2m/m 
as compared to WT mice (Hotelling t-tests for phase 
and amplitude comparisons, p< 0.001 for each gene) 
(Supplementary Figure S1A; Table 1).
The phase advance and amplitude dampening in 
the liver clock of Per2m/m translated into a 2-3 h phase 
advance of c-Myc (Figure 1B) and Wee1 circadian 
rhythms (Hotelling t-test, p< 0.05), and the suppression 
of the Ccnb1 and K-ras 24h rhythms as compared to WT 
mice (Figure 1B, Supplementary Figure S1B, Table 1). 
ATM expression displayed a similar circadian rhythm 
with a maximum at ZT9 and a trough at ZT19 in both 
genotypes. In addition, the 24-h mean mRNA expression 
was significantly decreased for P53, increased for Bcl-2 
and doubled for c-Myc in Per2m/m as compared to WT mice 
(ANOVA, p≤ 0.001) (Figure 1B, Table 1).
Liver IL-6 protein concentration displayed a 
circadian pattern in WT with a maximum at ZT11 
(Cosinor analysis, p= 0.04), but no such rhythm was found 
in Per2m/m mice (p= 0.17) (Supplementary Figure S1C). 
The 24-h mean concentration of liver IL6 was increased 
in Per2m/m, although not significantly so (p= 0.09). No 
circadian change was found for liver TNF-α concentration 
in either genotype, yet the 24-h mean level was decreased 
in Per2m/m as compared to WT mice (p= 0.017) (Figure 1C, 
Table 1).
Relevance of clock gene Per2 for liver 
carcinogenesis initiation processes
Here, the role of Per2 was investigated on both liver 
pathology and selected molecular biomarkers during the 
initiation stage of liver carcinogenesis. WT and Per2m/m 
mice received daily DEN (15 mg/kg ip) for 5 days a week 
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Figure 1: Moderation of selected liver clock, proliferation, genomic instability and pro-inflammatory cytokine patterns 
by Per2 loss-of-function. Each data point is mean of 5 mice at each of 6 Zeitgeber Times (ZT) for WT (dark circles) or Per2m/m mice 
(open circles). Circadian changes in mean ± SEM of mRNA expression for A. clock gene Bmal1; B. proliferation and genomic instability 
genes c-Myc, Ccnb1, and P53; C. TNF-α protein concentration in liver. Results from 2-way ANOVA: * p(genotype)≤ 0.01; † p(ZT)≤ 0.01; 
‡ p(interaction)≤ 0.01.
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over a 17 day-span (cumulative dose of 195 mg/kg). Liver 
samples were obtained in DEN-exposed animals at 6 
different time points, located 4 h apart.
Pathology findings
After being on DEN for 17 days, mice displayed 
few hepatic lesions associated with inflammatory foci 
and some apoptotic and necrotic cells. The histological 
features were supportive of early stage carcinogenesis 
processes, yet no gross difference was apparent between 
WT and Per2m/m mice.
Twenty-four hour patterns in selected gene expressions
The circadian transcription patterns of the genes 
studied after a 17-day exposure to DEN differed markedly 
according to Per2 mutation (Figure 2, Supplementary 
Figure S2). The mRNA expression of clock genes Bmal1, 
Rev-erbα, Clock, Cry1, and Cry2 exhibited statistically 
Table 1: Circadian rhythms of selected gene mRNA expressions and cytokine concentrations in the liver of control 
WT and Per2m/m mice in the absence of any DEN exposure (Results from cosinor analysis with τ= 24h)
Function Gene Genotype p Mesor [95% CL] Amplitude [95% 
CL]
Acrophase, ZT : min 
[95% CL]
Clock
Clock
WT <0.001 1.03 [0.91 to 1.15] 0.56 [0.38 to 0.73] 23:35 [22:20 to 00:45]
Per2m/m 0.13 0.97 [0.83 to 1.1] 0.19 22:25
Bmal1
WT <0.001 1.02 [0.84 to 1.19] 1.04 [0.8 to 1.28] 00:30 [23:30 to 1:30]
Per2m/m <0.001 0.82 [0.69 to 0.96] 0.74 [0.55 to 0.94] 20:45 [19:45 to 21:45]
Rev-
erbα
WT <0.001 0.86 [0.46 to 1.25] 1.24 [0.79 to 1.72] 8:05 [6:20 to 9:55]
Per2m/m <0.001 1.04 [0.82 to 1.25] 1.01 [0.7 to 1.31] 5:00 [3:50 to 6:10]
Cry1
WT <0.001 1.25 [0.99 to 1.51] 1.07 [0.71 to 1.43] 21:50 [20:30 to 23:10]
Per2m/m <0.001 0.82 [0.7 to 0.94] 0.44 [0.27 to 0.61] 16:40 [15:10 to 18:10]
Cry2
WT 0.04 1 [0.85 to 1.15] 0.25 [0.02 to 0.48] 13:35 [9:20 to 17:40]
Per2m/m 0.04 1.05 [0.93 to 1.17] 0.22 [0.05 to 0.39] 11:40 [8:25 to 15:00]
Genome 
instability
P53
WT 0.23 1.01 [0.91 to 1.11] 0.12 3:00
Per2m/m 0.15 0.81 [0.74 to 0.88] 0.09 1:30
Bcl2
WT 0.19 0.71 [0.62 to 0.81] 0.12 5:10
Per2m/m 0.63 0.98 [0.82 to 1.14] 0.1 22:40
ATM
WT 0.02 1.16 [1.04 to 1.29] 0.25 [0.08 to 0.42] 9:00 [6:00 to 12:00]
Per2m/m <0.001 1.22 [1.12 to 1.32] 0.34 [0.19 to 0.49] 8:20 [6:30 to 10:10]
Proliferation
Wee1
WT <0.001 1.24 [0.98 to 1.50] 1.02 [0.65 to 1.38] 13:20 [12:00 to 14:40]
Per2m/m <0.001 1.34 [1.15 to 1.52] 1.12 [0.86 to 1.38] 10:00 [9:00 to 11:00]
Ccnb1
WT 0.004 0.32 [0.23 to 0.41] 0.24 [0.11 to 0.37] 5:40 [3:25 to 7:40]
Per2m/m 0.25 0.41 [0.24 to 0.58] 0.19 23:20
c-Myc
WT 0.046 0.64 [0.54 to 0.74] 0.17 [0.04 to 0.3] 13:40 [10:20 to 17:00]
Per2m/m 0.038 1.27 [1.02 to 1.52] 0.46 [0.11 to 0.81] 11:40 [8:25 to 15:00]
K-ras
WT 0.009 0.82 [0.72 to 0.92] 0.24 [0.09 to 0.38] 23:20 [20:50 to 25:50]
Per2m/m 0.31 0.69 [0.6 to 0.78] 0.09 8:40
Inflammation
IL-6
WT 0.04 6.72 [5.8 to 7.64] 1.7 [0.4 to 3] 12:15 [8:50 to 15:40]
Per2m/m 0.17 7.55 [7.14 to 7.96] 0.55 10:00
TNF-α
WT 0.29 9.3 [8.1 to 10.5] 1.3 12:45
Per2m/m 0.93 7.45 6.52 to 8.38 0.25 14:20
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significant circadian variations for both WT and Per2m/m 
mice (2-way ANOVA: ZT effect, p< 0.001; Cosinor, p< 
0.03 to p< 0.001). The rhythms were phase advanced by 5 
h for Bmal1 (Figure 2A), by 4 h for Clock, Cry1 and Cry2, 
and by 7 h for Rev-erbα in Per2m/m as compared to WT 
(Supplementary Figure S2A, p< 0.001 for each gene). The 
circadian amplitudes of clock genes were also reduced by 
34 to 74% except for Cry2 in Per2m/m compared to WT (p 
<0.001) (Supplementary Figure S2A, Table 2).
Twenty four-hour changes were also statistically 
validated for the proliferation genes c-Myc, as wells as 
Wee1, Ccnb1, and K-ras, and for the genomic instability 
genes P53, ATM, and Bcl2 (Figure 2B, Supplementary 
Figure S2B) (2-way ANOVA: ZT effect, p< 0.01 for each 
gene). Circadian rhythms were validated with Cosinor for 
Wee1, Ccnb1, K-ras, ATM, and P53 in WT mice (p< 0.05 
to p< 0.001), but only for K-ras in Per2m/m (p= 0.006), 
while 12-h rhythms were found for c-Myc in both for 
Figure 2: Circadian gene or protein expressions during initiation phase of carcinogenesis. Each data point is mean of 
5-7 mice at each of 6 Zeitgeber Times (ZT) for WT (dark circles) or Per2m/m mice (open circles). Circadian changes in mean ± SEM of 
mRNA expression for A. clock gene Bmal1; B. proliferation and genomic instability genes c-Myc, Ccnb1, and P53; C. TNF-α protein 
concentration in liver. Results from 2-way ANOVA: * p(genotype)≤ 0.01; † p(ZT)≤ 0.01; ‡ p(interaction)≤ 0.01.
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WT and Per2m/m (p= 0.02 and p= 0.005, respectively), as 
well as for Wee1, Ccnb1, ATM, Bcl-2 in Per2m/m (p≤ 0.03 
for each gene). Per2 mutation was also associated with 
increased daily average mRNA expression of c-Myc 
by 66%, Ccnb1 by 55%, and Bcl-2 by 20% (p< 0.04 to 
p< 0.001) (Figure 2B, Table 2).
Liver IL-6 and TNF-α concentrations displayed 
marked 24-h changes in both genotypes (2-way ANOVA: 
ZT effect, p< 0.001; Cosinor with τ = 24h, p= 0.02 
to < 0.001) (Figure 2C, Supplementary Figure S2C, 
Table 2). Both mean IL-6 and TNF-α concentrations were 
significantly increased in Per2m/m as compared to WT 
(p= 0.003 and p< 0.001, respectively).
DEN-induced changes during carcinogenesis initiation 
according to Per2 mutation
Overall, the 17-day exposure to DEN markedly 
altered the circadian gene expression patterns, and did 
more so in the Per2m/m. In WT mice, DEN phase-advanced 
Table 2: Circadian rhythms of selected gene mRNA expressions and cytokine concentrations in the liver of WT and 
Per2m/m mice exposed to DEN over 17 days (Results from cosinor analysis with τ= 24h)
Function Gene Genotype p Mesor [95% CL] Amplitude [95% CL] Acrophase, ZT : min 
[95% CL]
Clock
Clock
WT <0.001 0.96 [0.89 to 1.03] 0.41 [0.29 to 0.53] 21:50 [20:40 to 23:00]
Per2m/m <0.001 0.85 [0.77 to 0.93] 0.27 [0.15 to 0.39] 17:40 [15:55 to 19:25]
Bmal1
WT <0.001 0.87 [0.76 to 0.98] 0.89 [0.73 to 1.05] 21:45 [21:00 to 22:30]
Per2m/m <0.001 0.64 [0.55 to 0.73] 0.42 [0.3 to 0.54] 17:00 [15:50 to 18:10]
Rev-erbα
WT <0.001 0.74 [0.57 to 0.91] 0.85 [0.61 to 1.09] 7:20 [6:20 to 8:20]
Per2m/m <0.001 0.71 [0.63 to 0.79] 0.39 [0.28 to 0.5] 00:10 [23:10 to 1:10]
Cry1
WT <0.001 1 [0.88 to 1.12] 1.03 [0.86 to 1.2] 20:30 [19:50 to 21:10]
Per2m/m <0.001 0.49 [0.43 to 0.55] 0.27 [0.19 to 0.35] 16:40 [15:30 to 17:50]
Cry2
WT 0.03 0.93 [0.84 to 1.02] 0.17 [0.05 to 0.29] 9:10 [6:00 to 12:20]
Per2m/m <0.001 0.84 [0.78 to 0.90] 0.18 [0.1 to 0.26] 5:35 [3:45 to 7:35]
Genome 
instability
P53
WT 0.04 1.14 [0.94 to 1.34] 0.38 [0.1 to 0.66] 7:40 [4:20 to 11:00]
Per2m/m 0.91 1.02 [1.06 to 1.34] 0.04 14:45
Bcl2
WT 0.08 0.93 [0.78 to 1.08] 0.26 22:50
Per2m/m 0.06 1.11 [1 to 1.22] 0.2 23:30
ATM
WT 0.007 1.12 [0.99 to 1.25] 0.32 [0.14 to 0.5] 18:50 [16:30 to 21:10]
Per2m/m 0.32 1.06 [0.94 to 1.18] 0.12 18:50
Proliferation
Wee1
WT 0.009 0.97 [0.78to 1.17] 0.42 [0.14 to 0.70] 13:10 [10:40 to 15:40]
Per2m/m 0.09 1.15 [0.95 to 1.35] 0.31 5:10
Ccnb1
WT 0.02 0.64 [0.48 to 0.8] 0.33 [0.11 to 0.55] 6:40 [3:40 to 9:40]
Per2m/m 0.19 0.99 [0.77 to 1.21] 0.28 7:00
c-Myc
WT 0.79 1.4 [1.12 to 1.68] 0.13 15:30
Per2m/m 0.43 2.33 [1.95 to 2.71] 0.34 3:20
K-ras
WT <0.001 0.88 [0.78 to 0.97] 0.39 [0.25 to 0.52] 21:20 [19:50 to 22:40]
Per2m/m 0.006 0.84 [0.73 to 0.94] 0.26 [0.11 to 0.41] 19:00 [16:30 to 21:30]
Inflammation
IL-6
WT 0.001 7.9 [7.1 to 8.7] 2.36 [1.18 to 3.54] 10:25 [8:30 to 12:20]
Per2m/m <0.001 9.5 [8.9 to 10.1] 1.7 [0.9 to 2.5] 12:00 [10:00 to 14:00]
TNF-α
WT 0.004 10 [8.6 to 11.4] 3.5 [1.5 to 5.5] 6:40 [4:30 to 8:50]
Per2m/m 0.023 15.57 [14.73 to 16.41] 1.7 [0.5 to 2.9] 10:45 [7:50 to 13:40]
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the mRNA expression patterns of the five clock genes and 
that of K-ras by 1 to 4 h, and nearly inverted the ATM 
rhythm, as compared to untreated controls (Hotelling 
t-test for phases: p= 0.01 to p< 0.001). DEN dampened 
the circadian amplitude of Bmal1, Rev-erbα, Clock, Cry2 
and Wee1 by 15 to 59% and amplified the 24-h rhythms of 
Ccnb1, K-Ras and ATM by 28 to 63% (Hotelling t-test for 
amplitude: p= 0.04 to p< 0.001) (Figures 1 and 2, and left 
panels in Supplementary Figures S1 and S2).
In Per2m/m, DEN treatment for 17 days phase-
advanced the 24-h rhythms in Bmal1, Rev-erbα and 
Cry2 by 4 to 6 hours (Hoteling t-test for phases, p< 
0.001), shortened the rhythm period from 24 h to 12 
h for c-Myc, Wee1 and Ccnb1, and induced a 24-h 
rhythm for K-ras (p= 0.03 to p= 0.005) as compared 
to untreated Per2m/m controls. The 24 h amplitude was 
reduced by 43% for Bmal1, 61% for Rev-erbα and 39% 
for Cry1 as compared to untreated controls (Hotelling 
t-test for amplitudes: p< 0.001 for each gene) (Figures 
1 and 2, and right panels in Supplementary Figures S1 
and S2).
DEN exposure significantly reduced the 24-h mean 
expression of Bmal1, Rev-erbα, Cry1 and Cry2 by 20 to 40% 
in Per2m/m and only that of Cry1 by 20% in WT. In contrast, 
DEN exposure nearly doubled the 24-h mean expression of 
c-Myc and that of Ccnb1 both in WT and Per2m/m with regard 
to their respective controls (p< 0.05 to p< 0.001) (Table 2).
Severe circadian disruption during carcinogenesis 
initiation stage in Per2m/m on DEN
The rest-activity and temperature circadian patterns 
were monitored using implanted telemetry sensors in 
WT and Per2m/m mice for 17 days before DEN exposure, 
and throughout the 17-day DEN-initiation stage of 
liver carcinogenesis. The circadian rhythm in plasma 
corticosterone was determined at completion of this 
initiation stage in DEN-treated mice and in untreated 
controls.
Both rest-activity and body temperature patterns 
were markedly dampened during DEN exposure with 
more severe apparent alteration in Per2m/m as compared to 
WT over the 17-days of DEN exposure (Figure 3A).
Cosinor analysis documented an acrophase advance 
by nearly 2 h and 30 min in Per2m/m for both rest-activity 
(ZT17:00 vs ZT19:20, p= 0.014) and body temperature 
Figure 3: DEN effects during initiation phase on circadian rhythms in rest-activity, body temperature and corticosterone 
rhythms according to Per2 mutation during early carcinogenesis. A. Chronograms of telemetered rest-activity (left) and body 
temperature (right) in WT and Per2m/m before and during daily DEN exposure for 17 days. B. Corresponding mean circadian acrophases in 
WT (dark circles) and Per2m/m (open circles). C. Corresponding mean circadian amplitudes in WT (dark boxes) and Per2m/m (open boxes). 
D. Twenty-four hour changes in mean plasma corticosterone concentration (±SEM) in untreated WT and Per2m/m mice (left panel) and in 
WT and Per2m/m mice after a 17-day DEN exposure (right panel). *p <0.05, **p <0.01.
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(ZT16:50 vs ZT19:30, p= 0.015) as compared to WT mice, 
before DEN administration (Figure 3B). The circadian 
amplitude was nearly halved for rest-activity (p= 0.03) and 
reduced by nearly 40% for body temperature (p= 0.009) 
in Per2m/m as compared to WT mice (Figure 3C). DEN 
exposure did not modify the circadian temperature 
acrophases, yet it induced 1-h phase advance for rest-activity 
in WT and a 2-h phase advance in Per2m/m (Hotelling t-test 
for phase comparisons, p= 0.004) (Figure 3B).
DEN reduced the circadian amplitude of rest-
activity by nearly 5.3-fold and 4.6-fold in WT and 
Per2m/m respectively (Hotelling t-test, p= 0.03) and halved 
that of temperature in both groups (Hotelling t-test for 
amplitudes, p= 0.02) (Figure 3C).
Plasma corticosterone was rhythmic in WT mice 
(Cosinor, p< 0.001), but not in Per2m/m both in untreated 
controls and in mice exposed to DEN, with 4.3-fold lower 
24-h mean corticosterone levels in treated Per2m/m as 
compared to WT (p< 0.001) (Figure 3D).
Liver carcinogenesis according to Per2 mutation
Subsequently, the role of Per2 was investigated 
regarding DEN-induced liver carcinogenesis from 
initiation to promotion and progression. WT and Per2m/m 
mice received daily DEN (15 mg/kg ip) for 5 days per 
week over 12 days followed with a 9-day DEN-free span. 
This allowed for the recovery from sustained body weight 
loss, during this initiation carcinogenesis stage (cumulative 
dose = 150 mg/kg) (Figure 4A). A reduced dose of DEN 
(12 mg/kg/day) was then administered according to the 
same 5-days on/2-days off schedule over 29 days during 
this promotion stage (cumulative dose = 252 mg/kg). 
Overall, the mice received a cumulative dose of 402 mg/
kg of DEN over a 50 day-span. They were euthanized 
after allowing for a 129-day span, corresponding to the 
carcinogenesis progression stage for histopathological 
analyses.
Increased DEN toxicity during carcinogenesis 
promotion stage in Per2m/m mice
The DEN daily dose had to be reduced from 
15 to 12 mg/kg, because of a rapid body weight loss 
during the carcinogenesis initiation stage, irrespective 
of Per2 mutation (8.9 ± 1.3 % in WT vs 10 ± 1.4 % in 
Per2m/m, p= 0.55). Following DEN re-exposure during 
the promotion stage, mean body weight loss reached a 
Figure 4: Systemic toxicity of DEN according to Per2 loss-of-function in the initiation, promotion and progression 
stages. A Relative body weight changes (mean ± SEM) in WT (dark circles) and Per2m/m mice (open circles) during and after DEN 
exposure. The daily DEN doses (mg/kg) are shown in italic, for corresponding exposure spans. B Histogram of serum levels of ALAT and 
ASAT (mean ± SEM) after DEN exposure in WT (dark box) and Per2m/m (open box) mice in the progression stage. Mean ± SEM ALAT and 
ASAT in untreated control mice is represented by the gray horizontal bar. C Survival rate in WT (dark circles) and Per2m/m (open circles) 
mice exposed to DEN over 180 days.
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second nadir 57 days after DEN treatment onset, which 
was ~twice as large in Per2m/m mice as compared to 
WT (12.3 ± 2.2 % vs 6.5 ± 1.3 %, p from ANOVA < 
0.001). Complete recovery of body weight was also 
slower in the Per2m/m as compared to WT (38 days vs 26 
days) (Figure 4A). The aspartate levels of both alanine 
aminotransferase (ALAT) and aspartate aminotransferase 
(ASAT) were increased by up to six- and four-fold 
respectively ~30 days after completion of DEN exposure 
as compared to untreated controls. However, no 
difference was found according to Per2 mutation over 
the 90-day span corresponding to the carcinogenesis 
progression stage (Figure 4B). No toxic death was 
encountered in the WT mice on DEN. In contrast, four 
Per2m/m mice died with severe liver alterations before 
study completion (p from log Rank= 0.009) (Figure 
4C). Two mice displayed histological evidence of liver 
inflammation, oval cell types, with major dysplasia and 
enlarged nuclei, associated with severe body weight loss 
(37.4%) or ascites on days 59 and 79 respectively. The 
liver histology of both other mice revealed inflammatory 
foci. In addition, precancerous dysplasia was found 
for that mouse dead on day 136, while 4 liver cancer 
nodules were identified in the mouse that died on day 
137. Only, this latter animal was counted among those 
that developed liver cancer.
Major DEN-induced circadian disruption in Per2m/m 
mice
The rest-activity and temperature circadian 
patterns were monitored in WT and Per2m/m mice 
for 5 days before DEN exposure, and throughout the 
initiation, promotion and progression stages of liver 
carcinogenesis using implanted telemetry sensors 
(Exp III), in order to assess the dynamics of circadian 
physiology disruption. Double-plot representations 
of both circadian biomarkers in individual mice 
revealed that the circadian disruption produced by 
DEN was transient for WT, and sustained for Per2m/m 
mice. The temperature rhythm appeared to be more 
sensitive to disruption as compared to rest-activity, 
and this was especially true during the progression 
carcinogenesis stage (Figure 5A and 5B). Moreover, a 
significant correlation was found between the circadian 
acrophases of both rhythms for WT mice (r= 0.571, 
p= 0.042) but not for Per2m/m individuals (r= 0.197, 
p= 0.518). This finding supports the coupling of both 
physiological rhythms in WT and the occurrence of 
internal desynchronization in Per2m/m as a result of DEN 
exposure (Figure 5C).
Cosinor analysis further indicated that both rest-
activity and temperature patterns displayed periodic 24-h 
Figure 5: Examples of circadian physiology records in mice according to Per2 loss-of-function and DEN exposure 
for 50 days (initiation and promotion stages). Representative double-plots of temperature A. and activity B. rhythms according to 
Per2 loss-of-function and DEN exposure. The vertical black lines indicate exposure to DEN or vehicle (control) for 7 weeks. C. Relation 
between acrophases of rest-activity and body temperature rhythms 7 weeks after DEN exposure onset in individual WT mice (left) and 
Per2m/m mice (right). Note robust coordination in WT and internal desynchronization in Per2m/m.
Oncotarget10www.impactjournals.com/oncotarget
changes in Per2m/m and WT mice for the 5 days preceding 
DEN exposure. A 1-h phase advance was statistically 
validated in Per2m/m for both rest-activity (ZT16:07 vs 
ZT17:07, Hotelling t-test, p= 0.016) and body temperature 
(ZT16:39 vs ZT17:45, p= 0.001) (Figure 6A). Although 
the baseline rest-activity amplitude was similar in both 
genotypes, that of body temperature was significantly 
lower in Per2m/m (0.7 vs 0.88°C, Hotelling T test, p< 
0.001) (Figure 6B).
DEN suppressed the circadian rhythm in rest-
activity for 2/13 WT (15%) and 8/13 Per2m/m (62%), and 
that in body temperature for 2/13 Per2m/m (15%) during 
the initiation and/or the promotion stages. In the WT 
mice with circadian rhythms, DEN reduced ~three-fold 
the circadian amplitude of rest-activity and halved that 
of body temperature as compared to baseline. Such effect 
was achieved during the carcinogenesis initiation stage 
for both genotypes. During the promotion stage however, 
the amplitudes in rest-activity and body temperature 
deteriorated down to 1/9 and 1/4 of their respective 
baseline values in Per2m/m mice while no further changes 
were noticed in WT (p< 0.001) (Figure 6B). Over this 
4-week span, the circadian phase was delayed by ~2 h for 
rest-activity and by 1 h for body temperature as compared 
to baseline in WT (Paired T-tests, p= 0.01 and p= 0.003, 
respectively). In contrast both of these rhythms were 
phase-advanced by 3 h and 2 h respectively in Per2m/m 
(Paired t-test, p= 0.04) (Figure 6A).
Accelerated progression of liver carcinogenesis in 
Per2m/m mice
All the mice were euthanized and inspected for 
liver, lung, kidney or other tumor deposits 178 days after 
the onset of the DEN administration protocol, i.e. at an 
advanced carcinogenesis progression stage. Macroscopic 
Figure 6: Dynamics of rest-activity and body temperature rhythms throughout liver carcinogenesis processes according 
to Per2 loss-of-function. A. Acrophase charts for rest-activity (left panel) and body temperature (right panel). Each acrophase (time of 
maximum in best-fitting 24-h cosine function) is displayed with its 95% C.L. for WT (dark circles) and Per2m/m (open circles) before, 
during the initial 3 weeks (weeks 1-3; initiation stage) and the subsequent 4 weeks on DEN (weeks 4-7; promotion stage), and after 
exposure (weeks 8-25; progression stage). B. Corresponding histograms of 24h mean amplitudes with 95% C.L. for rest- activity (left 
panel) and body temperature (right panel) in WT (dark boxes) and Per2m/m (open boxes). * p< 0.05; ** p< 0.001.
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tumor nodules were observed in all Per2m/m mice [Figure 
7A (I)]. Histological analysis revealed the occurrence 
of minor or severe liver dysplasia [Figure 7A (II)], 
as well as both hepatocellular carcinoma (HCC) and 
cholangiocarcinoma (CCA) [Figure 7A (III-IV)], and 
pre-neoplastic nodules, inflammatory infiltrations and 
apoptotic hepatocytes. DEN further induced primary 
lung tubulo-papillary tumor in 5 WT and 3 Per2m/m with 
associated inflammatory foci. A single HCC metastasis 
was found in the kidney of a WT mouse.
Histopathological analysis was performed on three 
parallel transverse liver sections equispaced by 1 mm. 
Liver tumor nodules, with diameters ranging from 1 to 
11 mm, were found in all the Per2m/m and in 77% of the 
WT mice. Histology revealed ~six times as many HCC 
as compared to CCA (69 vs 11), in both groups. The 
average number of tumors per animal, including HCC 
and CCA, was 3.7-fold as high in Per2m/m as compared to 
WT (Figure 7B) (Kruskal-Wallis ANOVA, p= 0.01). The 
number of tumor nodules ranged from 0 to 4 in WT mice, 
and from 1 to 10 in Per2m/m. As a result, the proportion of 
mice with more than 2 tumor nodules was ~five-fold as 
high in Per2m/m as compared to WT (80% vs 15 %, Fisher 
exact test, p= 0.003). The average number of HCC per 
mouse was 3.7-fold as high in Per2m/m mice as compared 
to WT (Kruskal-Wallis ANOVA, p< 0.001) (Figure 7C).
DISCUSSION
To our knowledge, this study is the first one 
that reveals the crucial role of clock gene Per2 in liver 
carcinogenesis. DEN was used here as a carcinogen for 
both initiation and promotion of primary liver cancers 
in mice. Mutation of clock gene Per2 increased nearly 
fivefold the rate of mice with two or more primary liver 
cancers as compared to WT exposed to the same DEN 
Figure 7: DEN-induced liver alterations according to Per2 loss-of-function found on day 178. A. Typical macroscopic 
view of a deeply reorganized liver with cancer nodules arising in a Per2m/m mouse (I); Typical microscopic view of large (left) or small 
(right) cell dysplasia coexisting in the same liver sample of a Per2m/m mouse and separated by a dark marker line (II); Microscopic view of 
hepatocarcinoma (III), and cholangiocarcinoma (IV). B. Number of tumor nodules per mouse liver in WT (black boxes) and Per2m/m (open 
boxes). C. Average number of hepatocarcinomas (open box) or cholangiocarcinomas (dark box) in WT and Per2m/m mice. *** p< 0.001.
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dose. Previous studies demonstrated that mutation or 
knock out of clock genes Per2, Cry1/Cry2 or Bmal1 also 
accelerated the development of lymphomas following 
whole body exposure to γ radiations [18, 19]. The clinical 
relevance of our findings is illustrated by the fact that Per2 
expression was also decreased in human HCC as well as 
in other human cancers, as compared to the corresponding 
healthy tissues [27, 28]. Furthermore, the down regulation 
of Per2 expression in human cancers was usually 
associated with poor patient outcomes [29]. In contrast, 
the overexpression of Per2 inhibited proliferation and 
arrested cell cycling in cancer cell lines, thus supporting 
the negative growth-regulatory properties of Per2 [16].
Circadian disruption resulting from an altered 
light-dark environment had been previously identified as 
a promoter of liver carcinogenesis in rats and mice [22, 
23]. In contrast, the current study showed that initiation, 
promotion and progression stages of liver carcinogenesis 
were regulated by Per2. Indeed, Per2 mutation resulted in 
profound circadian disruption of selected gene and protein 
expressions during the initiation stage, although no apparent 
difference was observed at histopathologic analysis of liver 
obtained after 17 days on DEN. Prior to DEN exposure, 
Per2 mutation was already associated with profound 
molecular circadian disruption in liver despite regular light-
dark exposure. Thus, both 24-h expressions and circadian 
amplitudes of Bmal1 and Cry1 were markedly reduced. In 
addition, a 2- to 5-h phase advance was shown for clock 
and cell cycle-related genes, supporting an alteration of the 
clock-cell cycle coupling [10] in Per2m/m. The 24-h mean 
mRNA expression of c-Myc was doubled in the liver of 
untreated Per2m/m as compared to WT mice in the current 
study. This was related to the demonstrated role of Bmal1 
as a repressor of proto-oncogene c-Myc through binding to 
its P1 promoter [18].
The several-fold higher rate of liver cancers in 
Per2m/m mice as compared to WT at ~6 months after the 
beginning of treatment was preceded by the up-regulation 
of several critical liver carcinogenesis pathways at 17 
days after DEN administration onset. Thus, molecular 
markers of proliferation, genomic instability, apoptosis, 
and inflammation were significantly deregulated in 
Per2m/m, as compared to WT, despite apparently similar 
extent of histological liver inflammation. DEN exposure 
further significantly dampened the circadian transcription 
amplitude of Bmal1, Rev-erbα, Cry1, and Clock in Per2m/m 
as compared to WT. This severe alteration of the liver 
clock translated into the up-regulation and/or the circadian 
deregulation of the selected molecular markers of cellular 
proliferation including c-Myc, Ccnb1, Wee1, and K-ras. 
DEN exposure had less prominent effects on the 24-h 
expression patterns of the selected genomic instability 
genes ATM and P53 both in WT and Per2m/m. In contrast, 
apoptosis induction was reported in cultured mouse 
primary hepatocytes exposed to DEN for 24 h, an effect 
which was suppressed in Clock mutant hepatocytes [30].
DEN exposure in the initiation stage has long been 
known as inducing hepatocyte deaths, activation of NF-κB 
pathway in liver macrophages, and liver inflammation [31, 
32]. In our study, histologic lesions were documented at 17 
days, with occasional deaths, occurring in Per2m/m mice 
over the subsequent 3 months. IL-6 and TNF-α proteins 
were significantly increased in Per2m/m as compared to WT, 
while their 24-h amplitudes were less in Per2m/m. During 
the initiation of carcinogenesis, NF-κB overexpression 
accelerates cellular proliferation and inhibits apoptosis 
through the activation of IL-6 and TNF-α genes [33, 34]. 
Indeed, Per2-/- mice, a construct which differed from 
Per2m/m by the lack of any PER2 protein, also displayed 
increased TNF-α expression jointly with liver cholestasis 
or fibrosis, in response to physical liver injury [35].
DEN metabolism also involves clock-controlled 
pathways, which were not explored here. DEN was 
administered at ZT11, near the end of the light span, 
coincidently with the physiologic peak in plasma 
corticosterone in WT mice. This hormone triggers 
the bioactivation of DEN by hepatic microsomes, 
thus potentiates its liver toxicity [36]. DEN is mainly 
bioactivated into ethyldiazonium ion by CYP2E1 and 
CYP2A5 in mouse liver [24]. Cyp2e1 displayed mRNA 
and protein circadian variations in mouse liver, with peak 
expression occurring in the late light span (ZT10), for 
mRNA, and in the early dark span (ZT15), for protein. 
Moreover, Cyp2e1 activation was suppressed by PER2 
[37]. Thus, Per2 mutation would expectedly enhance DEN 
bioactivation. However, clock-controlled glutathione-
related genes in liver also peaked in the late light span, 
resulting in highest levels of reduced glutathione near 
ZT15 [38]. This supported highest DEN detoxification 
near the middle of the activity phase of mouse rest-
activity circadian rhythm. Taken together, the available 
data revealed that DEN bioactivation and detoxification 
pathways were both controlled by the circadian clock in 
mouse liver. However, these opposite processes followed 
a coincident circadian pattern, thus suggesting their 
respective effects on DEN could antagonize each other. 
The plasma levels of liver ASAT and ALAT were increased 
up to six-fold as compared to controls at the beginning 
of the progression carcinogenesis stage, then decreased 
over about 2 months, then increased again. These changes 
reflected the complex dynamics in the underlying DEN-
induced chronic cirrhosis and fibrosis, which constitute 
the grounds on which liver cancers develop. Since no 
difference was found according to Per2 mutation, this 
supports the hypothesis that Per2 played a critical role for 
the development of liver cancers rather than for that of 
chronic liver disease.
The deleterious effects of DEN on circadian clocks 
during carcinogenesis initiation was also documented here 
using circadian biomarkers. Both rest-activity and core 
body temperature rhythms displayed severe disruption 
in WT mice, while an internal desynchronization was 
Oncotarget13www.impactjournals.com/oncotarget
found in Per2m/m. We hypothesized that the release of 
inflammatory cytokines resulting from initial acute 
liver damage could in turn disrupt circadian physiology, 
thus depriving molecular clocks and clock-controlled 
pathways in peripheral tissues from resetting time cues. 
Such desynchronization of molecular clocks could further 
alter xenobiotic metabolism and detoxification, and 
favor carcinogenic processes, and even more so in clock-
defective Per2m/m mice [39, 40]. Circadian disruption 
remained consistently worse in Per2m/m as compared to 
WT mice during both the promotion and the progression 
stages of liver carcinogenesis. Such profound and 
sustained alterations in the circadian timing system thus 
contributed to enhance cancer development throughout all 
three carcinogenesis stages.
In summary, the loss of function of Per2 critically 
deregulated the circadian clock and clock-controlled 
pathways, whose alteration contributed to three cancer 
hallmarks, within the initial 3 weeks of DEN exposure. As 
a result, the formation of liver cancers was increased by 
up to four-fold, six months after the onset of carcinogen 
exposure, Clock gene Per2 could thus represent a 
promising target for liver cancer prevention and therapy.
MATERIALS AND METHODS
Mice
Animal experiments were performed under the 
guidelines approved for animal experimental procedures 
by the French Ethical Committee (decree 87-848). Male 
129SvEvBrd / C57BL/6-Tyrc-Brd mice with or without 
constitutive Per2 mutation were used for all experiments 
[17]. The Per2m/m mice and their WT counterpart were a 
generous gift from Urs Albrecht (Freiburg, Switzerland). 
They were kept at 21°C to 23°C in chronobiologic 
facilities, with light intensity at cage level ranging from 
240 to 580 lux according to cage location. Mice were 
aged 8 to 14 weeks upon inclusion in each experiment, 
with 85% of them being 10-14 weeks old (Supplementary 
Table S1). They were stratified according to age, then 
allocated to treatment group, and synchronized with an 
alternation of 12 h of light (L) and 12 h of darkness (D) 
(LD 12:12) for at least 3 weeks before starting and during 
each experiment, and had free access to food and water. 
Zeitgeber Time (ZT) 0 corresponded to light onset, while 
ZT12 corresponded to dark onset.
Experimental design
The study involved three experiments (Exp). Exp 
I aimed at jointly determining the regulatory role of 
Per2 gene on circadian clock, proliferation, genomic 
instability, and inflammation both in the absence of DEN 
administration and during the carcinogenesis initiation 
stage, after 17-day DEN treatment. Thirty WT and 30 
Per2m/m mice were euthanized at 6 time points, located 4 
h apart, i.e. ZT3, 7, 11, 15, 19, and 23. Blood (200 μL) 
was sampled on heparin in order to determine plasma 
corticosterone concentration. A liver lobe was obtained 
and frozen in liquid nitrogen, then kept at -80 °C. Total 
RNA and proteins were extracted from each mouse liver 
for the determination of selected gene mRNA expressions, 
as well as selected cytokine concentrations.
Exp II assessed the role of Per2 on liver pathology 
(IIA) and several main molecular mechanisms (IIB) during 
the initiation stage of liver carcinogenesis. For Exp IIA, 
6 WT and 6 Per2m/m mice received daily intraperitoneal 
injection (i.p) of DEN (Sigma-Aldrich, Saint Quentin 
Fallavier, France) at ZT11 for 17 days (cumulative dose 
of 195 mg/kg). Twenty-four hours after the last injection, 
mice were sacrificed and livers were removed for 
histological studies.
For Exp IIB, 30 WT and 42 Per2m/m mice, received 
a cumulative dose of 195 mg/kg DEN (15 mg/kg/d i.p. at 
ZT11) over a 17-day span. Five WT and 5 Per2m/m mice 
underwent circadian monitoring of rest-activity and body 
temperature for 5 days before and during DEN exposure. 
Plasma corticosterone concentration and selected liver 
gene mRNA expressions, as well as liver IL-6 and TNF-α 
concentrations were determined in 5 WT and 7 Per2m/m 
every 4h for 24h.
Exp III determined the role of Per2 mutation in 
DEN-induced liver carcinogenesis, involving all three 
stages. Thirteen WT and 13 Per2m/m mice received a 
cumulative dose of 402 mg/kg of DEN, using a 5-days on 
and 2-days off schedule over an overall exposure duration 
of 50 days. Two control mice per genotype received 0.9% 
NaCl, solution. DEN was injected i.p. to mice aged 12-14 
weeks at ZT11 from day 1 to 12 at a daily dose of 15 mg/
kg, followed with a 9-day DEN-free interval, and DEN 
(12 mg/kg daily) from day 22 to 50. Body weight was 
recorded daily at ZT11 before each injection for 50 days, 
then every 3 days for 128 days. Mortality was checked 
daily. Blood (100 μl) was sampled from the retro-orbital 
sinus on days 79, 102, 130, 150, and 178, i.e. during the 
carcinogenesis progression stage, for the determinations 
of ASAT and ALAT concentrations, with a Synchron 
LX20 Clinical System (Beckman Coulter, Villepinte, 
France). All the mice underwent monitoring of rest-
activity and core body temperature for 5 days before DEN 
exposure, throughout DEN treatment, and subsequently 
until experiment completion. Mice were euthanized 178 
days after DEN administration onset for pathology and 
histology studies.
Circadian rest-activity and core body 
temperature rhythm monitoring
Mice underwent i.p. implantation of a telemetry 
sensor and radiotransmitter under isoflurane anesthesia 
2 weeks before starting effective recording of locomotor 
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activity and body temperature every 10 min (Physio Tel, 
TA 10 TA-F20, Data Sciences, St. Paul, Minnesota) (39). 
For Exp II, mice were monitored for 17 days before DEN 
treatment onset, and during the 17-day carcinogenesis 
initiation stage. For Exp III, body temperature and 
rest-activity were recorded for 5 days before DEN 
administration and until completion of experiment, i.e. 178 
days after DEN exposure onset.
Pathology and histological analyses
Gross pathology examination was performed on the 
12 WT and Per2m/m mice for Exp IIA and on all the 26 
DEN-exposed WT and Per2m/m mice included in Exp III, 
in order to identify any macroscopic abnormality either 
after intercurrent death or following sacrifice 17 days for 
Exp IIA and 178 days for Exp III after DEN exposure 
onset. Organs sampled involved whole liver in Exp IIA 
and whole liver, both lungs, and both kidneys in Exp 
III. They were removed immediately, then fixed in 4% 
formaldehyde for 24 h, then dehydrated and embedded 
into paraffin. Three 4 μm-thick serial histological sections 
were obtained 1 mm apart in each liver, and stained with 
hematoxylin-eosin-saffron. A senior pathologist (C.G.) 
carefully examined each slide under a light microscopic 
for counting all detectable tumor nodules, for measuring 
their diameter, and for identifying their histological 
characteristics, without any information on genotype or 
experimental conditions.
RNA extraction, cDNA synthesis, and RT-qPCR
Total liver RNA was isolated from the frozen 
tissue specimens with an acidic solution containing acid 
guanidinium thiocyanate, phenol, and chloroform (41). 
cDNA were synthesized using SuperScript Reverse 
Transcriptase kit (Invitrogen, Cergy Pontoise -France). 
Quantitative PCR (qPCR) was performed in a light cycler 
system instrument using Light Cycler 480 SYBR Green I 
Master kit (Roche, France). All primers were obtained from 
Invitrogen Life Technologies (Supplementary Table S2).
Plasma corticosterone and liver cytokines 
determinations
Blood (200 μL) was sampled on heparin from the 
retro-orbital sinus prior to mouse euthanizing. Blood 
was centrifuged at 5000 rpm, plasma extracted and 
frozen at -80 °C. Plasma corticosterone concentration 
was determined with ELISA (Enzo Life Sciences, 
Villeurbanne-France). Data were expressed as ng/mL of 
plasma.
Liver proteins were extracted with an established buffer 
(Tris 20 mM, EDTA 2 mM, EGTA 5 mM, DTT 0.5 mM, 
NaCl 100 Mm, and Triton 0.1%). The liver concentrations 
were determined with “BioPhotometer” for total proteins, 
and with commercially available ELISA kits (Invitrogen, 
Cergy Pontoise-France) for IL-6 and TNF-α. Cytokine 
concentrations in liver were expressed as pg/mg of proteins.
Statistical analyses
Mean ± standard error of the mean (SEM) were 
computed for all quantitative data according to sampling 
time (ZT), genotype (WT vs Per2m/m), experimental 
condition (DEN exposure vs no DEN). Group comparisons 
involved multiple way analyses of variance (ANOVA) 
with Scheffé’s contrast tests. Incidence data were 
compared with Chi-Square or Exact Fischer test.
Survival curves were compared with log-rank. Time 
series were first examined with chronogram inspection. 
Rest-activity and temperature time series were analyzed 
with spectral analysis through Fast Fourier Transform 
in order to determine the occurrence of a dominant 
period τ in the circadian domain. Cosinor analyses 
with τ= 24h were performed for all the 24h time series 
in order to determine mesor (24h mean), amplitude 
(half the difference between maximum and minimum 
value of fitted cosine function) and acrophase (timing 
of maximum, referred to ZT0). All parameters were 
computed with their 95% Confidence Limits. Statistical 
significance required a P value < 0.05. All statistical 
analyses were performed using SPSS statistical analysis 
software version 18 (Statistical Package for Social 
Sciences, Chicago, IL, USA).
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